Maryam Soleimani

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Journal: Nature communications

Published: October 09, 2025

Machine Learning Model Integrating Computed Tomography Image-Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer.

Machine Learning Model Integrating Computed Tomography Image-Derived Radiomics and Circulating miRNAs to Predict Residual Teratoma in Metastatic Nonseminoma Testicular Cancer.

Journal: JCO clinical cancer informatics

Published: August 25, 2025

Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada.

Real-world management and clinical outcomes of first line treatment of advanced renal cell carcinoma in older patients in Canada.

Journal: Journal of geriatric oncology

Published: August 06, 2025

The effect of oral belzutifan on retinal hemangioblastomas in von Hippel-Lindau syndrome.

The effect of oral belzutifan on retinal hemangioblastomas in von Hippel-Lindau syndrome.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: May 07, 2025

Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma.

Author Correction: Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma.

Journal: Scientific reports

Published: April 28, 2025

Detection of VHL variant on multigene panel testing for hereditary breast cancer: Implications for genetic counselling.

Detection of VHL variant on multigene panel testing for hereditary breast cancer: Implications for genetic counselling.

Journal: Cancer genetics

Published: April 15, 2025

Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma.

Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma.

Journal: NPJ precision oncology

Published: January 17, 2025

A Phase I/II Study of [177Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol.

A Phase I/II Study of [177Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 09, 2024

Abstracts of the 2024 Canadian Association of Medical Oncologists Annual Scientific Meeting.

Abstracts of the 2024 Canadian Association of Medical Oncologists Annual Scientific Meeting.

Journal: Current oncology (Toronto, Ont.)

Published: November 27, 2024

2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.

2024 CUA-KCRNC Expert Report: Management of non-clear cell renal cell carcinoma.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: November 05, 2024

Belzutifan: a novel therapeutic for the management of von Hippel-Lindau disease and beyond.

Belzutifan: a novel therapeutic for the management of von Hippel-Lindau disease and beyond.

Journal: Future oncology (London, England)

Published: April 19, 2024

Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma.

Circulating microRNA-155-3p levels predicts response to first line immunotherapy in patients with metastatic renal cell carcinoma.

Journal: Scientific reports

Published: November 28, 2023

Showing 1-12 of 26

Last Updated: 09/26/2026